+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Alexion Pharmaceuticals - logo

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare diseases. Alexion developed Soliris for the treatment of patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Soliris is approved in more than 50 countries for PNH and more than 40 countries for aHUS. Alexion's company headquarters are based Cheshire, Connecticut, United States.

Immunotherapy Drugs Market - Global Outlook & Forecast 2021-2026 - Product Thumbnail Image

Immunotherapy Drugs Market - Global Outlook & Forecast 2021-2026

  • Report
  • October 2021
  • 210 Pages
  • Global
From
Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030 - Product Thumbnail Image

Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030

  • Report
  • February 2020
  • 360 Pages
  • Global
From
Gene Therapies & Associated Vectors: Intellectual Property Landscape - Product Thumbnail Image

Gene Therapies & Associated Vectors: Intellectual Property Landscape

  • Report
  • April 2022
  • 131 Pages
  • Global
From
Rare Disease Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Rare Disease Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • October 2023
  • 130 Pages
  • Global
From
Myasthenia Gravis Treatment Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030 - Product Thumbnail Image

Myasthenia Gravis Treatment Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030

  • Report
  • November 2025
  • 185 Pages
  • Global
From
Neurometabolic Disorders Market by Disease Type, by Route of Administration, by End-User, and By Region - Product Thumbnail Image

Neurometabolic Disorders Market by Disease Type, by Route of Administration, by End-User, and By Region

  • Report
  • March 2024
  • 200 Pages
  • Global
From
Multiple Sclerosis Drugs Market Report 2026 - Product Thumbnail Image

Multiple Sclerosis Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
DNA Repair Drugs Market Report 2026 - Product Thumbnail Image

DNA Repair Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Drug Formulation Market Report 2026 - Product Thumbnail Image

Drug Formulation Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
CRISPR Technologies: Intellectual Property Landscape(Featuring Historical and Contemporary Patent Filing Trends, Prior Art Search Expressions, Patent Valuation Analysis, Patentability, Freedom to Operate, Pockets of Innovation, Existing White Spaces, and Claims Analysis) - Product Thumbnail Image

CRISPR Technologies: Intellectual Property Landscape(Featuring Historical and Contemporary Patent Filing Trends, Prior Art Search Expressions, Patent Valuation Analysis, Patentability, Freedom to Operate, Pockets of Innovation, Existing White Spaces, and Claims Analysis)

  • Report
  • August 2022
  • 121 Pages
  • Global
From
Myasthenia Gravis- Pipeline Insight, 2025 - Product Thumbnail Image

Myasthenia Gravis- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Transverse Myelitis - Pipeline Insight, 2025 - Product Thumbnail Image

Transverse Myelitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Orphan Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Thumbnail Image

Orphan Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • January 2026
  • 180 Pages
  • Global
From
Skeletal Dysplasia Market - Product Thumbnail Image

Skeletal Dysplasia Market

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Neuromyelitis Optica Spectrum Disorder (NMOSD) - Pipeline Insight, 2025 - Product Thumbnail Image

Neuromyelitis Optica Spectrum Disorder (NMOSD) - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 60 Pages
  • Global
From
Orphan Drugs Market Report 2026 - Product Thumbnail Image

Orphan Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Paroxysmal Nocturnal Hemoglobinuria Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Paroxysmal Nocturnal Hemoglobinuria Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • August 2024
  • 86 Pages
  • Global
From
Atypical Hemolytic Uremic Syndrome Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Atypical Hemolytic Uremic Syndrome Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • August 2024
  • 83 Pages
  • Global
From
Myasthenia Gravis - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Myasthenia Gravis - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • April 2024
  • 287 Pages
  • Global
From
Atypical Hemolytic Uremic Syndrome (aHUS) - Market Insight, Epidemiology and Market Forecast - 2032 - Product Thumbnail Image

Atypical Hemolytic Uremic Syndrome (aHUS) - Market Insight, Epidemiology and Market Forecast - 2032

  • Report
  • January 2024
  • 158 Pages
  • Global
From
Loading Indicator